Cure My Disease

Don't miss your cure!

Log in / Sign up

← Back to home

Rempex

Clinical trials sponsored by Rempex, explained in plain language.

Upcoming readouts

Trials from this sponsor expected to report results within the next 12 months.

New antibiotic vabomere tested in kids with tough UTIs Results expected Jan 2027 (estimated)

Browse trials soon ready across all sponsors →

Not yet finished but already full! 1 Completed 1

New antibiotic vabomere tested in kids with tough UTIs

Disease control Ongoing

This study tests the safety of an antibiotic called Vabomere in children aged 3 months to 12 years who have complicated urinary tract infections, including kidney infections. The children receive the medicine through an IV while in the hospital. Researchers monitor for side effec…

Phase 2 • Sponsor: Rempex (a wholly owned subsidiary of Melinta Therapeutics, LLC) • Aim: Disease control

Last updated Jun 27, 2026 13:02 UTC